Latest Posts
About This Stock
More About This Stock
Read
Puma (PBYI) Q1 Loss Narrows, Focus Remains On Neratinib
Article By:
Zacks Investment Research
Thursday, May 11, 2017 10:10 AM EDT
Puma Biotechnology, Inc. reported a first-quarter 2017 loss of $1.97 per share narrower than the Zacks Consensus Estimate of a loss of $2.08 and the year-ago loss of $2.19.